APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis Vaccine Treatment

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.

Selected research

Industry Growth & Trends

Global Tuberculosis Vaccine Treatment Industry Growth and Trends Forecast to 2032

28 December 2025100 pages

Choose your research edition.

Industry ResearchTuberculosis Vaccine Treatment Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis Vaccine Treatment Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Tuberculosis Vaccine Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis Vaccine Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis Vaccine Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.

In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.

Read the full market overview

The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.

Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.

Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.

Report Scope

This report provides a structured, data-driven view of the global Tuberculosis Vaccine Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tuberculosis Vaccine Treatment market size, estimates, and forecasts are presented in terms of sales volume (K Dose) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tuberculosis Vaccine Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tuberculosis Vaccine Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tuberculosis Vaccine Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tuberculosis Vaccine Treatment Market by Company

Merck

Japan BCG Lab

Serum Institute of India

AJ Vaccines

BioFarma

GreenSignal Bio Pharma

China National Biotec

Biomed Lublin

Taj Pharmaceuticals

Ataulpho de Paiva

IVAC

Queen Saovabha Mem. Inst

Microgen

Tuberculosis Vaccine Treatment Segment by Type

Immune Vaccine

Therapy Vaccine

Tuberculosis Vaccine Treatment Segment by Application

Self-Procurement

UNICEF

Other

Tuberculosis Vaccine Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Vaccine Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Vaccine Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Vaccine Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tuberculosis Vaccine Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tuberculosis Vaccine Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immune Vaccine Table 2. Major Company of Therapy Vaccine Table 3. Global Tuberculosis Vaccine Treatment Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 5. Global Tuberculosis Vaccine Treatment Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tuberculosis Vaccine Treatment Sales Market Share in Value by Type (2021-2026) Table 8. Global Tuberculosis Vaccine Treatment Price by Type (2021-2026) & (USD/K Dose) Table 9. Global Tuberculosis Vaccine Treatment Sales by Type (2027-2032) & (K Dose) Table 10. Global Tuberculosis Vaccine Treatment Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tuberculosis Vaccine Treatment Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tuberculosis Vaccine Treatment Sales Market Share in Value by Type (2027-2032) Table 13. Global Tuberculosis Vaccine Treatment Price by Type (2027-2032) & (USD/K Dose) Table 14. North America Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 15. North America Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 17. Europe Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 19. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 21. Latin America Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 23. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (US$ Million) Table 24. Tuberculosis Vaccine Treatment Industry Trends Table 25. Tuberculosis Vaccine Treatment Industry Drivers Table 26. Tuberculosis Vaccine Treatment Industry Opportunities and Challenges Table 27. Tuberculosis Vaccine Treatment Industry Restraints Table 28. Global Tuberculosis Vaccine Treatment Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tuberculosis Vaccine Treatment Revenue Market Share by Company (2021-2026) Table 30. Global Tuberculosis Vaccine Treatment Sales by Company (2021-2026) & (K Dose) Table 31. Global Tuberculosis Vaccine Treatment Sales Share by Company (2021-2026) Table 32. Global Tuberculosis Vaccine Treatment Market Price by Company (2021-2026) & (USD/K Dose) Table 33. Global Tuberculosis Vaccine Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tuberculosis Vaccine Treatment Major Company Production Sites and Headquarters Table 35. Global Tuberculosis Vaccine Treatment Company, Product Type & Application Table 36. Global Tuberculosis Vaccine Treatment Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tuberculosis Vaccine Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tuberculosis Vaccine Treatment Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tuberculosis Vaccine Treatment Sales by Region (2021-2026) & (K Dose) Table 41. Global Tuberculosis Vaccine Treatment Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tuberculosis Vaccine Treatment Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tuberculosis Vaccine Treatment Sales Market Share in Value by Region (2021-2026) Table 44. Global Tuberculosis Vaccine Treatment Sales (K Dose), Value (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 45. Global Tuberculosis Vaccine Treatment Sales by Region (2027-2032) & (K Dose) Table 46. Global Tuberculosis Vaccine Treatment Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tuberculosis Vaccine Treatment Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tuberculosis Vaccine Treatment Sales Market Share in Value by Region (2027-2032) Table 49. Global Tuberculosis Vaccine Treatment Sales (K Dose), Value (US$ Million), Price (USD/K Dose) and Gross Margin (2027-2032) Table 50. Global Tuberculosis Vaccine Treatment Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 52. Global Tuberculosis Vaccine Treatment Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tuberculosis Vaccine Treatment Sales Market Share in Value by Application (2021-2026) Table 55. Global Tuberculosis Vaccine Treatment Price by Application (2021-2026) & (USD/K Dose) Table 56. Global Tuberculosis Vaccine Treatment Sales by Application (2027-2032) & (K Dose) Table 57. Global Tuberculosis Vaccine Treatment Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tuberculosis Vaccine Treatment Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tuberculosis Vaccine Treatment Sales Market Share in Value by Application (2027-2032) Table 60. Global Tuberculosis Vaccine Treatment Price by Application (2027-2032) & (USD/K Dose) Table 61. North America Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 62. North America Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 64. Europe Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 66. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 68. Latin America Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 70. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 74. Merck Tuberculosis Vaccine Treatment Product Portfolio Table 75. Merck Recent Development Table 76. Japan BCG Lab Company Information Table 77. Japan BCG Lab Business Overview Table 78. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 79. Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio Table 80. Japan BCG Lab Recent Development Table 81. Serum Institute of India Company Information Table 82. Serum Institute of India Business Overview Table 83. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 84. Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio Table 85. Serum Institute of India Recent Development Table 86. AJ Vaccines Company Information Table 87. AJ Vaccines Business Overview Table 88. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 89. AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolio Table 90. AJ Vaccines Recent Development Table 91. BioFarma Company Information Table 92. BioFarma Business Overview Table 93. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 94. BioFarma Tuberculosis Vaccine Treatment Product Portfolio Table 95. BioFarma Recent Development Table 96. GreenSignal Bio Pharma Company Information Table 97. GreenSignal Bio Pharma Business Overview Table 98. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 99. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio Table 100. GreenSignal Bio Pharma Recent Development Table 101. China National Biotec Company Information Table 102. China National Biotec Business Overview Table 103. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 104. China National Biotec Tuberculosis Vaccine Treatment Product Portfolio Table 105. China National Biotec Recent Development Table 106. Biomed Lublin Company Information Table 107. Biomed Lublin Business Overview Table 108. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 109. Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolio Table 110. Biomed Lublin Recent Development Table 111. Taj Pharmaceuticals Company Information Table 112. Taj Pharmaceuticals Business Overview Table 113. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 114. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio Table 115. Taj Pharmaceuticals Recent Development Table 116. Ataulpho de Paiva Company Information Table 117. Ataulpho de Paiva Business Overview Table 118. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 119. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolio Table 120. Ataulpho de Paiva Recent Development Table 121. IVAC Company Information Table 122. IVAC Business Overview Table 123. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 124. IVAC Tuberculosis Vaccine Treatment Product Portfolio Table 125. IVAC Recent Development Table 126. Queen Saovabha Mem. Inst Company Information Table 127. Queen Saovabha Mem. Inst Business Overview Table 128. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 129. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolio Table 130. Queen Saovabha Mem. Inst Recent Development Table 131. Microgen Company Information Table 132. Microgen Business Overview Table 133. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 134. Microgen Tuberculosis Vaccine Treatment Product Portfolio Table 135. Microgen Recent Development Table 136. North America Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 137. North America Tuberculosis Vaccine Treatment Sales by Country (2021-2026) & (K Dose) Table 138. North America Tuberculosis Vaccine Treatment Sales Market Share by Country (2021-2026) Table 139. North America Tuberculosis Vaccine Treatment Sales Forecast by Country (2027-2032) & (K Dose) Table 140. North America Tuberculosis Vaccine Treatment Sales Market Share Forecast by Country (2027-2032) Table 141. North America Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Tuberculosis Vaccine Treatment Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Tuberculosis Vaccine Treatment Market Share by Country (2021-2026) Table 144. North America Tuberculosis Vaccine Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Tuberculosis Vaccine Treatment Market Share Forecast by Country (2027-2032) Table 146. Europe Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 147. Europe Tuberculosis Vaccine Treatment Sales by Country (2021-2026) & (K Dose) Table 148. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2021-2026) Table 149. Europe Tuberculosis Vaccine Treatment Sales Forecast by Country (2027-2032) & (K Dose) Table 150. Europe Tuberculosis Vaccine Treatment Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Tuberculosis Vaccine Treatment Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Tuberculosis Vaccine Treatment Market Share by Country (2021-2026) Table 154. Europe Tuberculosis Vaccine Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Tuberculosis Vaccine Treatment Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Country (2021-2026) & (K Dose) Table 158. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Tuberculosis Vaccine Treatment Sales Forecast by Country (2027-2032) & (K Dose) Table 160. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Tuberculosis Vaccine Treatment Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Tuberculosis Vaccine Treatment Market Share by Country (2021-2026) Table 164. Asia-Pacific Tuberculosis Vaccine Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Tuberculosis Vaccine Treatment Market Share Forecast by Country (2027-2032) Table 166. Latin America Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 167. Latin America Tuberculosis Vaccine Treatment Sales by Country (2021-2026) & (K Dose) Table 168. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Country (2021-2026) Table 169. Latin America Tuberculosis Vaccine Treatment Sales Forecast by Country (2027-2032) & (K Dose) Table 170. Latin America Tuberculosis Vaccine Treatment Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Tuberculosis Vaccine Treatment Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Tuberculosis Vaccine Treatment Market Share by Country (2021-2026) Table 174. Latin America Tuberculosis Vaccine Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Tuberculosis Vaccine Treatment Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2021-2026) & (K Dose) Table 178. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Tuberculosis Vaccine Treatment Sales Forecast by Country (2027-2032) & (K Dose) Table 180. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Tuberculosis Vaccine Treatment Market Share by Country (2021-2026) Table 184. Middle East and Africa Tuberculosis Vaccine Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Tuberculosis Vaccine Treatment Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Tuberculosis Vaccine Treatment Distributors List Table 189. Tuberculosis Vaccine Treatment Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Tuberculosis Vaccine Treatment Image Figure 2. Global Tuberculosis Vaccine Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis Vaccine Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Tuberculosis Vaccine Treatment Sales (2021-2032) & (K Dose) Figure 5. Immune Vaccine Image Figure 6. Global Immune Vaccine Sales YoY Growth (2021-2032) & (K Dose) Figure 7. Therapy Vaccine Image Figure 8. Global Therapy Vaccine Sales YoY Growth (2021-2032) & (K Dose) Figure 9. Global Tuberculosis Vaccine Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tuberculosis Vaccine Treatment Market Share by Type 2025 VS 2032 Figure 11. North America Tuberculosis Vaccine Treatment Sales Market Share in Volume by Type in 2025 Figure 12. North America Tuberculosis Vaccine Treatment Sales Market Share in Value by Type in 2025 Figure 13. Europe Tuberculosis Vaccine Treatment Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tuberculosis Vaccine Treatment Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tuberculosis Vaccine Treatment Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tuberculosis Vaccine Treatment Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tuberculosis Vaccine Treatment Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Self-Procurement Image Figure 24. Global Self-Procurement Sales YoY Growth (2021-2032) & (K Dose) Figure 25. UNICEF Image Figure 26. Global UNICEF Sales YoY Growth (2021-2032) & (K Dose) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Dose) Figure 29. Global Tuberculosis Vaccine Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Tuberculosis Vaccine Treatment Market Share by Application 2025 VS 2032 Figure 31. North America Tuberculosis Vaccine Treatment Sales Market Share in Volume by Application in 2025 Figure 32. North America Tuberculosis Vaccine Treatment Sales Market Share in Value by Application in 2025 Figure 33. Europe Tuberculosis Vaccine Treatment Sales Market Share in Volume by Application in 2025 Figure 34. Europe Tuberculosis Vaccine Treatment Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share in Value by Application in 2025 Figure 37. Latin America Tuberculosis Vaccine Treatment Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Tuberculosis Vaccine Treatment Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share in Value by Application in 2025 Figure 41. North America Tuberculosis Vaccine Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 42. North America Tuberculosis Vaccine Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Tuberculosis Vaccine Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Tuberculosis Vaccine Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tuberculosis Vaccine Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 46. Europe Tuberculosis Vaccine Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tuberculosis Vaccine Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Tuberculosis Vaccine Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 50. Asia-Pacific Tuberculosis Vaccine Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tuberculosis Vaccine Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Tuberculosis Vaccine Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tuberculosis Vaccine Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 54. Latin America Tuberculosis Vaccine Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tuberculosis Vaccine Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Tuberculosis Vaccine Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 58. Middle East and Africa Tuberculosis Vaccine Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Tuberculosis Vaccine Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Tuberculosis Vaccine Treatment Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Tuberculosis Vaccine Treatment Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Vaccine
  • Therapy Vaccine
Applications
  • Self-Procurement
  • UNICEF
  • Other
Companies covered
  • Merck
  • Japan BCG Lab
  • Serum Institute of India
  • AJ Vaccines
  • BioFarma
  • GreenSignal Bio Pharma
  • China National Biotec
  • Biomed Lublin
  • Taj Pharmaceuticals
  • Ataulpho de Paiva
  • IVAC
  • Queen Saovabha Mem. Inst
  • Microgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tuberculosis Vaccine Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tuberculosis Vaccine Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tuberculosis Vaccine Treatment Market by Type
  6. 1.3.1 Immune Vaccine
  7. 1.3.2 Therapy Vaccine
  8. 1.4 Global Tuberculosis Vaccine Treatment Market Size by Type
  9. 1.4.1 Global Tuberculosis Vaccine Treatment Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tuberculosis Vaccine Treatment Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tuberculosis Vaccine Treatment Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tuberculosis Vaccine Treatment Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tuberculosis Vaccine Treatment Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tuberculosis Vaccine Treatment Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tuberculosis Vaccine Treatment Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tuberculosis Vaccine Treatment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tuberculosis Vaccine Treatment Industry Trends
  2. 2.2 Tuberculosis Vaccine Treatment Industry Drivers
  3. 2.3 Tuberculosis Vaccine Treatment Industry Opportunities and Challenges
  4. 2.4 Tuberculosis Vaccine Treatment Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tuberculosis Vaccine Treatment Revenue (2021-2026)
  2. 3.2 Global Top Players by Tuberculosis Vaccine Treatment Sales (2021-2026)
  3. 3.3 Global Top Players by Tuberculosis Vaccine Treatment Price (2021-2026)
  4. 3.4 Global Tuberculosis Vaccine Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tuberculosis Vaccine Treatment Major Company Production Sites & Headquarters
  6. 3.6 Global Tuberculosis Vaccine Treatment Company, Product Type & Application
  7. 3.7 Global Tuberculosis Vaccine Treatment Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tuberculosis Vaccine Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tuberculosis Vaccine Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tuberculosis Vaccine Treatment Tier 1, Tier 2, and Tier 3
4 Tuberculosis Vaccine Treatment Regional Status and Outlook
  1. 4.1 Global Tuberculosis Vaccine Treatment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tuberculosis Vaccine Treatment Historic Market Size by Region
  3. 4.2.1 Global Tuberculosis Vaccine Treatment Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tuberculosis Vaccine Treatment Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tuberculosis Vaccine Treatment Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tuberculosis Vaccine Treatment Forecasted Market Size by Region
  7. 4.3.1 Global Tuberculosis Vaccine Treatment Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tuberculosis Vaccine Treatment Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tuberculosis Vaccine Treatment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tuberculosis Vaccine Treatment by Application
  1. 5.1 Tuberculosis Vaccine Treatment Market by Application
  2. 5.1.1 Self-Procurement
  3. 5.1.2 UNICEF
  4. 5.1.3 Other
  5. 5.2 Global Tuberculosis Vaccine Treatment Market Size by Application
  6. 5.2.1 Global Tuberculosis Vaccine Treatment Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Tuberculosis Vaccine Treatment Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Tuberculosis Vaccine Treatment Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Tuberculosis Vaccine Treatment Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Tuberculosis Vaccine Treatment Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Tuberculosis Vaccine Treatment Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Tuberculosis Vaccine Treatment Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Tuberculosis Vaccine Treatment Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Tuberculosis Vaccine Treatment Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Japan BCG Lab
  8. 6.2.1 Japan BCG Lab Company Information
  9. 6.2.2 Japan BCG Lab Business Overview
  10. 6.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio
  12. 6.2.5 Japan BCG Lab Recent Developments
  13. 6.3 Serum Institute of India
  14. 6.3.1 Serum Institute of India Company Information
  15. 6.3.2 Serum Institute of India Business Overview
  16. 6.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio
  18. 6.3.5 Serum Institute of India Recent Developments
  19. 6.4 AJ Vaccines
  20. 6.4.1 AJ Vaccines Company Information
  21. 6.4.2 AJ Vaccines Business Overview
  22. 6.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolio
  24. 6.4.5 AJ Vaccines Recent Developments
  25. 6.5 BioFarma
  26. 6.5.1 BioFarma Company Information
  27. 6.5.2 BioFarma Business Overview
  28. 6.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BioFarma Tuberculosis Vaccine Treatment Product Portfolio
  30. 6.5.5 BioFarma Recent Developments
  31. 6.6 GreenSignal Bio Pharma
  32. 6.6.1 GreenSignal Bio Pharma Company Information
  33. 6.6.2 GreenSignal Bio Pharma Business Overview
  34. 6.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio
  36. 6.6.5 GreenSignal Bio Pharma Recent Developments
  37. 6.7 China National Biotec
  38. 6.7.1 China National Biotec Company Information
  39. 6.7.2 China National Biotec Business Overview
  40. 6.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 China National Biotec Tuberculosis Vaccine Treatment Product Portfolio
  42. 6.7.5 China National Biotec Recent Developments
  43. 6.8 Biomed Lublin
  44. 6.8.1 Biomed Lublin Company Information
  45. 6.8.2 Biomed Lublin Business Overview
  46. 6.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolio
  48. 6.8.5 Biomed Lublin Recent Developments
  49. 6.9 Taj Pharmaceuticals
  50. 6.9.1 Taj Pharmaceuticals Company Information
  51. 6.9.2 Taj Pharmaceuticals Business Overview
  52. 6.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio
  54. 6.9.5 Taj Pharmaceuticals Recent Developments
  55. 6.10 Ataulpho de Paiva
  56. 6.10.1 Ataulpho de Paiva Company Information
  57. 6.10.2 Ataulpho de Paiva Business Overview
  58. 6.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolio
  60. 6.10.5 Ataulpho de Paiva Recent Developments
  61. 6.11 IVAC
  62. 6.11.1 IVAC Company Information
  63. 6.11.2 IVAC Business Overview
  64. 6.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 IVAC Tuberculosis Vaccine Treatment Product Portfolio
  66. 6.11.5 IVAC Recent Developments
  67. 6.12 Queen Saovabha Mem. Inst
  68. 6.12.1 Queen Saovabha Mem. Inst Company Information
  69. 6.12.2 Queen Saovabha Mem. Inst Business Overview
  70. 6.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolio
  72. 6.12.5 Queen Saovabha Mem. Inst Recent Developments
  73. 6.13 Microgen
  74. 6.13.1 Microgen Company Information
  75. 6.13.2 Microgen Business Overview
  76. 6.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Microgen Tuberculosis Vaccine Treatment Product Portfolio
  78. 6.13.5 Microgen Recent Developments
7 North America by Country
  1. 7.1 North America Tuberculosis Vaccine Treatment Sales by Country
  2. 7.1.1 North America Tuberculosis Vaccine Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tuberculosis Vaccine Treatment Sales by Country (2021-2026)
  4. 7.1.3 North America Tuberculosis Vaccine Treatment Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tuberculosis Vaccine Treatment Market Size by Country
  6. 7.2.1 North America Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tuberculosis Vaccine Treatment Market Size by Country (2021-2026)
  8. 7.2.3 North America Tuberculosis Vaccine Treatment Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tuberculosis Vaccine Treatment Sales by Country
  2. 8.1.1 Europe Tuberculosis Vaccine Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tuberculosis Vaccine Treatment Sales by Country (2021-2026)
  4. 8.1.3 Europe Tuberculosis Vaccine Treatment Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tuberculosis Vaccine Treatment Market Size by Country
  6. 8.2.1 Europe Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tuberculosis Vaccine Treatment Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tuberculosis Vaccine Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tuberculosis Vaccine Treatment Sales by Country
  2. 9.1.1 Asia-Pacific Tuberculosis Vaccine Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tuberculosis Vaccine Treatment Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tuberculosis Vaccine Treatment Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tuberculosis Vaccine Treatment Market Size by Country
  6. 9.2.1 Asia-Pacific Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tuberculosis Vaccine Treatment Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tuberculosis Vaccine Treatment Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tuberculosis Vaccine Treatment Sales by Country
  2. 10.1.1 South America Tuberculosis Vaccine Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tuberculosis Vaccine Treatment Sales by Country (2021-2026)
  4. 10.1.3 South America Tuberculosis Vaccine Treatment Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tuberculosis Vaccine Treatment Market Size by Country
  6. 10.2.1 South America Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tuberculosis Vaccine Treatment Market Size by Country (2021-2026)
  8. 10.2.3 South America Tuberculosis Vaccine Treatment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country
  2. 11.1.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tuberculosis Vaccine Treatment Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Country
  6. 11.2.1 Middle East and Africa Tuberculosis Vaccine Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tuberculosis Vaccine Treatment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tuberculosis Vaccine Treatment Value Chain Analysis
  2. 12.1.1 Tuberculosis Vaccine Treatment Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tuberculosis Vaccine Treatment Production Mode & Process
  7. 12.2 Tuberculosis Vaccine Treatment Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tuberculosis Vaccine Treatment Distributors
  10. 12.2.3 Tuberculosis Vaccine Treatment Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst